ReviewCritical care (London, England)2026
Vascular ultrasound in patients with mechanical circulatory support devices: from pre-implant assessment to post-decannulation surveillance.
Review in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mechanical circulatory support (MCS) devices, including extracorporeal membrane oxygenation (ECMO), left ventricular assist devices (LVADs), and intra-aortic balloon pumps (IABP), are increasingly used in patients with severe cardiac or cardiorespiratory failure. Despite major technical advances, vascular complications related to cannulation, device support, and decannulation remain frequent. Duplex ultrasound (DUS) is the primary vascular imaging modality because it is fast, can be performed at the patient’s bedside, is repeatable, and provides functional data via Doppler imaging. However, this is a specialized examination requiring expertise, as the flows are significantly altered by MCS, and the ultrasound findings are specific. This review summarizes current applications of DUS in patients supported with extracardiac MCS devices, organized into three key phases: pre-implant assessment, monitoring during mechanical support, and post-decannulation surveillance. Pre-implant DUS allows detailed evaluation of arterial and venous anatomy, vessel diameter, patency, and wall morphology, guiding cannulation strategy and cannula selection while facilitating ultrasound-guided percutaneous access. During MCS support, DUS plays a critical role in assessing limb perfusion, cannula positioning, and diagnosing vascular complications, particularly in patients unable to report ischemic symptoms. After decannulation, systematic ultrasound surveillance enables early detection of access-related complications, including thrombosis, pseudoaneurysm, arteriovenous fistula, arterial dissection, and acute limb ischemia. The objective is to guide the ultrasound practitioner in performing and interpreting DUS at each stage of the assessment of critically ill patients with an MCS device.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.